Transaera, Inc. | $10,500,000 | (Nov 5, 2024)
Algebrik AI | $4,000,000 | (Nov 5, 2024)
cloudsquid | $1,000,000 | (Nov 5, 2024)
Paterna Biosciences
United States
- Salt Lake City, UT
- 29/10/2024
- Seed
- $6,000,000
Paterna BioSciences, Inc. is a pioneering biotechnology company dedicated to solving the significant challenges of male infertility. We recognize the critical gap in male fertility treatment and are committed to helping people on their path to parenthood. Our innovative in-vitro spermatogenesis (IVS) technology is poised to transform the fertility landscape, offering new hope and innovative solutions to those struggling to conceive.
Led by a team of world-renowned scientists and physicians, we are advancing research into clinical applications. Our mission is to make parenthood a reality for more families through ethical, scientifically advanced fertility solutions.
Did you know?
*1 in 8 couples struggle with infertility.
*50% of in vitro fertilization (IVF) procedures fail.
*50% of infertility is linked to men.
*Male infertility treatment has been stagnant since 1992. Paterna is the first to develop a truly new treatment for male infertility since then.
With a strong foundation in science and a commitment to innovation, Paterna BioSciences is uniquely positioned to lead the next generation of male fertility treatments. We are actively seeking funding to accelerate our clinical development and commercialization efforts, bringing our life-changing technology to families worldwide.
We help make parenthood possible.
Learn more at www.PaternaBio.com
Contact us: info@paternabio.com
A New Paradigm in Human Reproduction.
- Industry Biotechnology Research
- Website https://paternabio.com/
- LinkedIn https://www.linkedin.com/company/paternabiosciences/
Related People
Alex Pastuszak, MD, PhDCo Founder
United States -
Salt Lake City, Utah
I am an experienced physician-scientist-entrepreneur focused on starting, leading, and building companies that will positively impact healthcare across the spectrum of services, therapeutics, and devices.
Chief Operating Officer, Paterna Biosciences
Chief Medical Officer, Contraline
President, Clinical Care, Chief Medical & Scientific Officer, Vault Health
Founder & CMO, Woven Health
Associate Professor in Andrology / Male Infertility at University of Utah
Entrepreneurial Endeavors:
• Chief Operating Officer, Paterna Biosciences (2023)
• Chief Medical Officer, Contraline (2021)
• President, Clinical Care and Chief Medical & Scientific Officer, Vault Health (2019)
• Founder & CMO of Woven Health Inc. (2013), a digital health company developing the mobile platform for patient care team engagement, designed to enhance the productivity of healthcare professionals, improve the quality and safety of patient care, and reduce costs for healthcare institutions.
• Conception and development of "Vas Reverse" iPhone app (2012) to guide decision-making by patients seeking vasectomy reversal and urologic surgeons who perform these procedures.
Clinical / Research Accomplishments:
• Successful clinical and basic science researcher
- Basic science interests focused on genetics of Peyronie's Disease and male infertility
• Clinical research interests targeting men's health, male infertility, Peyronie's Disease, hormone replacement, male sexual dysfunction.
• Over 140 peer-reviewed publications, 2 textbooks
Background:
• Born and raised in New York City
• Undergraduate education at Yale University
• Medical school and graduate training at UCSF
• Residency and fellowship at Baylor College of Medicine in Houston
• Recreational endeavors - wine enthusiast, amateur chef and and outdoor / health-focused fun as an opportunity to get healthy and brainstorm new ideas.
Cintoo | $40,246,701 | (Nov 5, 2024)
Further | $4,100,000 | (Nov 5, 2024)
Plato | $6,500,000 | (Nov 5, 2024)
Advex AI | $3,500,000 | (Nov 5, 2024)
Birl | $647,878 | (Nov 5, 2024)
Insider. | $500,000,000 | (Nov 5, 2024)
OpenOrigins | $4,500,000 | (Nov 1, 2024)
Persana AI | $2,300,000 | (Nov 1, 2024)
Definition Health | $7,412,756 | (Nov 1, 2024)